FDA addresses accuracy concerns with rapid COVID-19 testThe US Food and Drug Administration (FDA) says it's working with Abbott Laboratories to address potential false-negative results provided by the company's rapid coronavirus test.In a news release yesterday, the FDA said it's evaluating the information about inaccurate results reported for the Abbott ID NOW COVID-19 assay, which can provide results within 5 to 13 minutes.
A preprint study published earlier this week found that the test missed between 33% and 48% of positive coronavirus samples at a New York City hospital.
The FDA has also received 15 reports of adverse event related to false-negative test results."We will continue to study the data available and are working with the